WO2007023426A2 - Measurement of pulse wave velocity - Google Patents

Measurement of pulse wave velocity Download PDF

Info

Publication number
WO2007023426A2
WO2007023426A2 PCT/IB2006/052835 IB2006052835W WO2007023426A2 WO 2007023426 A2 WO2007023426 A2 WO 2007023426A2 IB 2006052835 W IB2006052835 W IB 2006052835W WO 2007023426 A2 WO2007023426 A2 WO 2007023426A2
Authority
WO
WIPO (PCT)
Prior art keywords
sensor
transducer
pathway
subject
pwv
Prior art date
Application number
PCT/IB2006/052835
Other languages
French (fr)
Other versions
WO2007023426A3 (en
Inventor
Jens Muehlsteff
Olaf Such
Jeroen A. J. Thijs
Robert Elfring
Original Assignee
Koninklijke Philips Electronics N.V.
Philips Intellectual Property & Standards Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips Electronics N.V., Philips Intellectual Property & Standards Gmbh filed Critical Koninklijke Philips Electronics N.V.
Priority to EP06795674A priority Critical patent/EP1921987A2/en
Priority to JP2008527558A priority patent/JP2009505710A/en
Publication of WO2007023426A2 publication Critical patent/WO2007023426A2/en
Publication of WO2007023426A3 publication Critical patent/WO2007023426A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0285Measuring or recording phase velocity of blood waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/02108Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • A61B5/02125Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave propagation time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/0507Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  using microwaves or terahertz waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813Specially adapted to be attached to a specific body part
    • A61B5/6824Arm or wrist

Definitions

  • the invention relates to an apparatus to measure pulse wave velocity, PWV, along a pathway in the cardiovascular system of a subject, with a first sensor for placement at the surface of the subject, to detect a first signal originating from a first position on a pathway in the cardiovascular system of the subject, the first signal detected at a first time, the first sensor coupled to a processor, and a second sensor for placement at the surface of the subject, to detect a second signal originating from a second position on the pathway in the cardiovascular system of the subject, the second signal detected at a second time, the second sensor coupled to the processor, the first and second positions situated a distance apart along the pathway, the processor arranged to calculate the PWV from the values of the first position, the second position, the first time and the second time.
  • PWV pulse wave velocity
  • Noninvasive Assessment of Vascular Mechanics in Mice by Craig J. Hartley et al, Proceedings of the Second Joint EMBS/BMES Conference, October 23-26, 2002 discloses the measurement of velocity pulse arrival times utilizing doppler ultrasound for determining pulse-wave velocity. Simultaneous measurements of velocity are made at two sites separated by a known distance. The two acquired signals are displayed and the difference in pulse arrival times extracted to calculate pulse wave velocity, PWV.
  • WO0176473 discloses the measurement of flow along an anatomical flow conduit using mechanical or pressure sensors placed along the external surface of the body at some known distance apart.
  • the sensors are attached to a rigid support means designed to wrap around a limb, by which the sensors can be brought into reliable contact with the body surface.
  • the sensors detect pressure or mechanical signals palpable at the body surface.
  • An option is included to time the detection of the second signal relative to an electrical start signal, for example an ECG measurement.
  • the support means is quite restrictive and difficult to place. Further, by measuring pressure or mechanical signals at the surface of the body the apparatus does not measure the time difference between arterial pulses directly, but rather measures a secondary signal from which PWV is then calculated.
  • Pulse Wave Velocity for Cardiovascular Characterization by David S. Charles and Martin D. Fox, IEEE, discloses the measurement of PWV in the human body by placing doppler ultrasound probes a known distance along an arterial pathway, detecting doppler signals at each probe and using the time difference between the detection of each signal to calculate PWV.
  • An option is provided to use ECG instead of the first doppler ultrasound probe. In this latter case the ECG provides a start signal from which to time the arrival at the second probe of the initial pulse generated at the heart.
  • the doppler ultrasound probe can only provide the required signal if the probe is correctly and carefully angled onto the surface of the skin. This requires skilled and experienced personnel and therefore limits the use of this measurement apparatus to situations in which such skilled and experienced staff are available.
  • At least one sensor is a transducer arranged to emit electromagnetic signals at a certain frequency and detect doppler shifted reflected electromagnetic signals representative of a pulsatile motion occurring at the respective position in the cardiovascular system.
  • Electromagnetic signals reflect from any boundary between materials with differing dielectric constants.
  • the feature of using a transducer arranged to emit electromagnetic signals and detect doppler shifted return signals allows the emission into the body of a signal which can be reflected from any boundary between two tissue types with differing dielectric constants and which can encode any movement of those boundaries which has a component along the direction of propagation of the electromagnetic signals. Therefore these signals can be used to detect the passing of a pulse along a cardiovascular route in the body and can therefore be used to measure the pulse transit time.
  • the measurement of pulse transit time can be coupled to the measured or calculated distance between sensors that measure the passing pulse and can be combined to calculate the pulse wave velocity, or PWV.
  • the pulse wave velocity can be used as an indicator of the physiological status of an artery and of the patient's hemodynamic status.
  • the heart as the organ which pumps blood around the body, is subdivided into 4 chambers, 2 atria which receive blood entering the heart and 2 larger ventricles which pump blood out of the heart.
  • Deoxygenated blood returning from the body enters the right atrium and is pumped out to the lungs through the right ventricle.
  • Oxygenated blood returning from the lungs enters the left atrium of the heart and is pumped via the left ventricle, the largest chamber in the heart, into the rest of the body via the vascular system.
  • the entire system of heart and blood vessels is known as the cardiovascular system.
  • the blood vessels are differentiated into the arteries, capillaries and veins.
  • Arteries are muscular and essentially tubular blood vessels capable of withstanding the pulsatile flow of blood ejected from the heart.
  • the pumping action of the heart causes blood to enter the arterial system in a series of strong bursts and the arterial walls are evolved to withstand the cyclical distension and contraction caused by the passing of each bolus of blood as it is pumped out.
  • the arterial system distributes blood away from the heart and into the capillary network where oxygen carried by the red blood cells transfers into the surrounding tissue and waste products transfer into the blood cells. From there the blood, now essentially deoxygenated and containing waste products, enters the venous system, or system of veins, where it is transferred back up to the heart.
  • each bolus of blood as it is pumped out of the heart and along the arterial system causes a pulsatile distension of the arterial walls to travel along the artery. It is this passing pulsatile movement which is detected by the transducer and which allows the transducer to be used for the calculation of PWV.
  • the passing pulse detected by the transducer occurs when an arterial pulse is transmitted along an arterial pathway.
  • the passing of the pulse of blood and the associated pulsatile distension of the surrounding arterial tissue causes doppler shifting of the reflected radar and allows a signal to be detected which indicates that a pulse has passed below the stationary transducer.
  • the detection of this signal allows the passing of the pulse to be timed and thereby allows the measurement of the transit time of the pulse along a distance along the arterial route, or pathway.
  • the invention does not require an air tight or other coupling contact between the surface of the skin and the surface of the transducer because electromagnetic signals are transmissable through air. Therefore use of the apparatus does not require the use of any gel. Therefore specifically it can be seen that the invention achieves the object of the calculation of PWV without the use of acoustic gel.
  • the invention has the further advantage that it does not require a direct placement against bare skin but can be placed against clothing.
  • the invention has the further advantage that it does not require a rigid construction to attach the doppler transducer to the skin surface but can merely be placed manually and held.
  • two transducers are utilized, placed a distance apart along an arterial pathway.
  • Particularly advantageous sites for the placement of the transducers is along the inner, or medial, surface of the arm.
  • Signals from both transducers can be detected and processed to identify the passing of an arterial pulse below the transducers and further to identify the minimum time between pulses and therefore to identify the time difference between the passing of the pulse below the upper transducer and the arrival of the pulse at the lower transducer.
  • This time difference can be used along with knowledge of the distance at which the transducers are placed apart to calculate the PWV, as is known in the art.
  • an ECG arrangement is used to identify the production of an arterial pulse and the transducer is used to identify the passing of the pulse at some point further along the arterial tree.
  • the time difference between the measurement of the ECG signal and the detection of the signal from the transducer can be calculated, and as is known in the art, used along with knowledge of the position of the doppler transducer to calculate PWV.
  • the transducer is used for the first sensor and the second sensor is a photoplethysmography sensor.
  • Further possibilities include using an audio-microphone, or some other sensor receptive to sound, positioned on the thorax to pick up heart sounds.
  • the apparatus of the invention can be used with a transducer arranged to produce electromagnetic signals of frequency in a range of between 400 MHz and 5 GHz. This range produces reflected signals from the passing pulsatile motion. However, the apparatus works in a particularly advantageous manner when the frequency is in a range of between 800MHz and 4 GHz.
  • Transducers for the detection of doppler shifted signals are commercially available, often for the purposes of far field detection of movement, for example Radar measurements of traffic speed. It is now found, according to the invention that such transducers can also be used for near field measurements and are surprisingly suitable for detecting the passing of pulses in the cardiovascular system.
  • an antenna emits an electromagnetic wave which, when it is reflected from the surfaces of an object moving with a component of velocity non-transverse to the impinging electromagnetic wave, produces a shift in the frequency of the electromagnetic wave reflected back to the antenna. This shift in frequency is called the doppler shift.
  • This doppler shifted reflected wave is then detected by an antenna in the transducer, which may or may not be the emitting transducer.
  • the relative speed of movement of the reflecting object is encoded in the frequency shift of the detected reflected wave and this value can be extracted using known techniques.
  • the transducer advantageously described contains a 2.45 GHz oscillator operating in continuous mode. It is known that electromagnetic radiation is strongly absorbed in human tissue at around the frequencies of 2 to 10 GHz, but it is found, according to a highly advantageous embodiment of the invention, that the radiation produced from an antenna operating at 2.45 GHz, although absorbed and scattered to some extent by layers of tissue, produces a detectable signal.
  • a particularly advantageous embodiment utilizes a commercially available KMY 24 unit made by Micro Systems Engineering GmbH. It contains a 2.45 GHz oscillator and receiver in the same housing and works in continuous wave mode.
  • the module comprises a four layered epoxy-multilayer-board with SMD-components and with triplate- filter-structures to minimize the emission of harmonics.
  • the dimensions of the beam are, amongst other things, dependent on the dimensions of the antenna and in this case the unit contains an optimized patch antenna with minimized dimensions and a width of 3.5 cm, producing a beam with a near field radius of 2 cm.
  • the receiver is sensitive enough to process signals that are reflected by the passing of a pulse through the emitted electromagnetic beam.
  • the technical steps to be performed in the processing of the recorded data to provide an output of PWV can be undertaken by a person skilled in the art using known data processing techniques.
  • the invention also relates to a method of calculating pulse wave velocity
  • a first time is calculated at which a first signal from a first pulse is detected by a first sensor, the first pulse originating from a first position on a pathway in the cardiovascular system of the subject
  • a second time is calculated at which a second signal from a second pulse is detected by a second sensor, the second pulse originating from a second position on the pathway in the cardiovascular system of the subject, the first and second positions separated by a distance along the pathway
  • PWV is calculated from the values of the first position, the second position, the first time and the second time, and in which at least one sensor is a transducer arranged to emit electromagnetic signals at a certain frequency and detect doppler shifted reflected electromagnetic signals representative of a pulsatile motion occurring at the respective position in the cardiovascular system.
  • Fig. 1 shows a high level block diagram of the features of a transducer used advantageously in the apparatus of the invention.
  • Fig. 2 shows items of an embodiment of the apparatus of the invention applied to a human arm.
  • Fig. 3 shows output signals from the apparatus of Fig. 2.
  • Fig. 4 shows a further embodiment of the apparatus of the invention applied to a subject.
  • Fig. 5 shows a typical ECG trace which is used in the second embodiment of the invention.
  • Fig. 6 shows output signals from the transducer and the ECG apparatus of the second embodiment, shown in Fig. 4, when the transducer is applied to the upper arm.
  • Fig. 7 shows output signals from the transducer and the ECG apparatus of the second embodiment, shown in Fig. 4, when the transducer is applied to the wrist.
  • FIG. 1 shows a high level block diagram of the features of a transducer used advantageously in the apparatus of the invention.
  • Processing electronics 101 instruct a duplexer 102 to send electromagnetic signals of frequency f s which are emitted by an antenna 103. Reflected electromagnetic signals doppler shifted to frequency f r are received by the antenna 103, passed back to the duplexer 102 and sent to processing electronics 104 which receives the signal and calculates fo the shift in frequency between the emitted and received electromagnetic signals, as is known in the art.
  • a single antenna 103 is shown here, separate antennas may be used for sending and receiving the electromagnetic signals.
  • the shift in frequency fo is communicated to a processor 105 which performs synchronization and analysis.
  • FIG. 2 shows the apparatus of the first embodiment of the invention.
  • two transducers are applied to the arm of a subject and measure the times at which a signal is returned from the pulsatile motion along the arm caused by blood flow.
  • the first transducer 201 is positioned over the brachial artery of the arm.
  • the second transducer 202 is adventitiously positioned over the radial artery which provides a clear signal.
  • the second transducer 203 can also be positioned so that the beam of electromagnetic signals is doppler shifted from pulsatile flow along the ulna artery.
  • the skilled person will understand that the exact positioning of the two transducers is chosen to measure PWV along the arterial pathway of interest and transducers must be adjusted to provide the best signal.
  • the transducer must be held motionless for a few seconds against the skin or clothing to allow movement artifacts to decrease and to allow whatever signal is received to be detected. It is apparent if the transducer has been misplaced to the extent that no pulsatile flow occurs in the beam of the electromagnetic signals, for in that case no signal is received.
  • Figure 3 shows a plot of the doppler shifted signals received from the apparatus of the first embodiment, as shown in Figure 2, and shows two traces 301 and 302, each from one of the transducers, plotted against time.
  • the signal which occurs first temporally 301 is from the transducer of the first embodiment which is placed in the upper position on the arm.
  • the signals are synchronously recorded.
  • the time difference of a pulse passing each transducer is clearly visible and in this case is 50 ms.
  • Standard algorithms known by the skilled person, are used to automatically extract the peak-to-peak time and these are used along with the known distance between the sensors to calculate PWV, as is known in the art. It is possible to place the transducers at other parts of the body, for example along the pathways taken by arteries in the leg.
  • the PWV which can be as high as 12 m/s, is higher than the flow velocity of blood, which is less than 1 m/s.
  • FIG 4 shows a further embodiment of the apparatus of the invention applied to a subject.
  • the second sensor is the transducer 401 and an arrangement of ECG electrodes 402, 403, 404 and processing device 405 is used to acquire the first signal.
  • the signal is the ECG signal from the heart itself.
  • measurements from electrocardiography, ECG show that the heart pumps in a cyclical fashion and allows the identification of certain phases in the hearts electrical sequence.
  • Figure 5 shows a typical output trace from an ECG measurement.
  • the characteristic spikes shown in a typical trace are labeled P, Q, R, S and T. It is known that the P spike, or wave, is representative of the depolarization, or excitation, of the atria.
  • QRS spikes are representative of the excitation of the ventricles.
  • the QRS-complex masks any signal from the repolarisation of the atria.
  • T spike, or T wave is representative of the repolarisation of the ventricles.
  • Figure 6 shows the output signals from the transducer 601 and the ECG apparatus 602 of the second embodiment when the transducer is applied to the upper arm and therefore detects a return signal from movement of the brachial artery.
  • standard algorithms as is known in the art, can be used to extract the time differences between the R peak and characteristic points of the doppler radar signal, as shown, and these are used, as is known in the art, to calculate PWV.
  • Figure 7 shows a similar output, in this case from the transducer 701 and the ECG apparatus 702 of the second embodiment when the transducer is applied to the wrist and therefore detects a return signal from movement of the radial artery.
  • standard algorithms as is known in the art, can be used to extract the time differences between the R peak and characteristic points of the doppler radar signal, as shown, and these are used, as is known in the art, to calculate PWV.
  • a photoplethysmography sensor is used as the second sensor.
  • This embodiment is particularly useful during surgery when a photoplethysmography sensor is placed on the tip of a finger to monitor blood oxygenation during anesthesia.
  • the doppler transducer can be applied anywhere along the arm where access is possible under the constraints of the surgical procedure and where a suitable signal can be found.
  • the photoplethysmography sensor designed to detect small changes in blood volume, is used to detect the arrival of pulsatile blood flow in the tip of the finger.
  • the PWV calculated using this embodiment can be used to provide information about the physiological status of the arteries of the upper arm during surgery.
  • a microphone is used as the first sensor. This is particularly useful to get rid of the typically unknown pre-ejection period compared with the embodiment detecting the ECG via a first sensor, because the ECG represents the electrical excitation of the heart and on the mechanical motion of blood.
  • the doppler transducer can be applied anywhere along the arm or leg.
  • the microphone detects heart sounds (e.g. opening and closing of the heart valves) from the thorax, which are well understood and enables the calculation of well defined time points of the start and end of a blood bolus.
  • pulse transit time and pulse wave velocity can be correlated to the blood pressure of an individual enabling beat-to-beat blood pressure readings.
  • pulse wave velocity can be used to measure both relative arterial blood pressure changes and absolute arterial blood pressure via appropriate calibration techniques, as is known in the art, utilizing beat-to-beat blood pressure values.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

An apparatus is described to measure pulse wave velocity, PWV, along a pathway in the cardiovascular system of a subject and comprising a first sensor coupled to a processor, a second sensor coupled to the processor, the processor arranged to calculate the PWV from measured and calculated values of the sensors. At least one sensor is a transducer arranged to emit electromagnetic signals at a certain frequency and detect doppler shifted reflected electromagnetic signals representative of a pulsatile motion occurring at the respective position in the cardiovascular system. The transducer can be applied directly to the skin, or can be applied to clothing covering skin, and allows the calculation of pulse wave velocity, PWV, without the use of acoustic gel.

Description

Measurement of pulse wave velocity
The invention relates to an apparatus to measure pulse wave velocity, PWV, along a pathway in the cardiovascular system of a subject, with a first sensor for placement at the surface of the subject, to detect a first signal originating from a first position on a pathway in the cardiovascular system of the subject, the first signal detected at a first time, the first sensor coupled to a processor, and a second sensor for placement at the surface of the subject, to detect a second signal originating from a second position on the pathway in the cardiovascular system of the subject, the second signal detected at a second time, the second sensor coupled to the processor, the first and second positions situated a distance apart along the pathway, the processor arranged to calculate the PWV from the values of the first position, the second position, the first time and the second time.
It is known that the pulse wave velocity, PWV, of the arterial pulse of an individual is dependent on the health of the individual and therefore can be used to diagnose arterial pathology.
Noninvasive Assessment of Vascular Mechanics in Mice, by Craig J. Hartley et al, Proceedings of the Second Joint EMBS/BMES Conference, October 23-26, 2002 discloses the measurement of velocity pulse arrival times utilizing doppler ultrasound for determining pulse-wave velocity. Simultaneous measurements of velocity are made at two sites separated by a known distance. The two acquired signals are displayed and the difference in pulse arrival times extracted to calculate pulse wave velocity, PWV.
WO0176473 discloses the measurement of flow along an anatomical flow conduit using mechanical or pressure sensors placed along the external surface of the body at some known distance apart. The sensors are attached to a rigid support means designed to wrap around a limb, by which the sensors can be brought into reliable contact with the body surface. The sensors detect pressure or mechanical signals palpable at the body surface. An option is included to time the detection of the second signal relative to an electrical start signal, for example an ECG measurement. However, the support means is quite restrictive and difficult to place. Further, by measuring pressure or mechanical signals at the surface of the body the apparatus does not measure the time difference between arterial pulses directly, but rather measures a secondary signal from which PWV is then calculated.
Pulse Wave Velocity for Cardiovascular Characterization, by David S. Charles and Martin D. Fox, IEEE, discloses the measurement of PWV in the human body by placing doppler ultrasound probes a known distance along an arterial pathway, detecting doppler signals at each probe and using the time difference between the detection of each signal to calculate PWV. An option is provided to use ECG instead of the first doppler ultrasound probe. In this latter case the ECG provides a start signal from which to time the arrival at the second probe of the initial pulse generated at the heart. As described in the text, the doppler ultrasound probe can only provide the required signal if the probe is correctly and carefully angled onto the surface of the skin. This requires skilled and experienced personnel and therefore limits the use of this measurement apparatus to situations in which such skilled and experienced staff are available. Further, use of doppler ultrasound requires acoustic gel between the probe and the skin in order to provide a good acoustical match. The gel is sticky and wet to the touch and transfers readily upon contact, making it difficult to clean up. Also patients frequently dislike the sensation of being in contact with the gel.
It is an object of the invention to provide an alternative apparatus to measure PWV directly but which does not require the use of acoustic gel.
This is achieved according to the invention whereby at least one sensor is a transducer arranged to emit electromagnetic signals at a certain frequency and detect doppler shifted reflected electromagnetic signals representative of a pulsatile motion occurring at the respective position in the cardiovascular system. Electromagnetic signals reflect from any boundary between materials with differing dielectric constants. The feature of using a transducer arranged to emit electromagnetic signals and detect doppler shifted return signals allows the emission into the body of a signal which can be reflected from any boundary between two tissue types with differing dielectric constants and which can encode any movement of those boundaries which has a component along the direction of propagation of the electromagnetic signals. Therefore these signals can be used to detect the passing of a pulse along a cardiovascular route in the body and can therefore be used to measure the pulse transit time. As is known by the skilled person, the measurement of pulse transit time can be coupled to the measured or calculated distance between sensors that measure the passing pulse and can be combined to calculate the pulse wave velocity, or PWV. As is known, the pulse wave velocity can be used as an indicator of the physiological status of an artery and of the patient's hemodynamic status.
The heart, as the organ which pumps blood around the body, is subdivided into 4 chambers, 2 atria which receive blood entering the heart and 2 larger ventricles which pump blood out of the heart. Deoxygenated blood returning from the body enters the right atrium and is pumped out to the lungs through the right ventricle. Oxygenated blood returning from the lungs enters the left atrium of the heart and is pumped via the left ventricle, the largest chamber in the heart, into the rest of the body via the vascular system. The entire system of heart and blood vessels is known as the cardiovascular system. The blood vessels are differentiated into the arteries, capillaries and veins. Arteries are muscular and essentially tubular blood vessels capable of withstanding the pulsatile flow of blood ejected from the heart. The pumping action of the heart causes blood to enter the arterial system in a series of strong bursts and the arterial walls are evolved to withstand the cyclical distension and contraction caused by the passing of each bolus of blood as it is pumped out. The arterial system distributes blood away from the heart and into the capillary network where oxygen carried by the red blood cells transfers into the surrounding tissue and waste products transfer into the blood cells. From there the blood, now essentially deoxygenated and containing waste products, enters the venous system, or system of veins, where it is transferred back up to the heart. The passing of each bolus of blood as it is pumped out of the heart and along the arterial system causes a pulsatile distension of the arterial walls to travel along the artery. It is this passing pulsatile movement which is detected by the transducer and which allows the transducer to be used for the calculation of PWV.
The passing pulse detected by the transducer occurs when an arterial pulse is transmitted along an arterial pathway. The passing of the pulse of blood and the associated pulsatile distension of the surrounding arterial tissue causes doppler shifting of the reflected radar and allows a signal to be detected which indicates that a pulse has passed below the stationary transducer. The detection of this signal allows the passing of the pulse to be timed and thereby allows the measurement of the transit time of the pulse along a distance along the arterial route, or pathway.
The invention does not require an air tight or other coupling contact between the surface of the skin and the surface of the transducer because electromagnetic signals are transmissable through air. Therefore use of the apparatus does not require the use of any gel. Therefore specifically it can be seen that the invention achieves the object of the calculation of PWV without the use of acoustic gel.
It has the further advantage that it does not require a direct placement against bare skin but can be placed against clothing. The invention has the further advantage that it does not require a rigid construction to attach the doppler transducer to the skin surface but can merely be placed manually and held.
Several advantageous embodiments are now described. In the first, two transducers are utilized, placed a distance apart along an arterial pathway. Particularly advantageous sites for the placement of the transducers is along the inner, or medial, surface of the arm. Signals from both transducers can be detected and processed to identify the passing of an arterial pulse below the transducers and further to identify the minimum time between pulses and therefore to identify the time difference between the passing of the pulse below the upper transducer and the arrival of the pulse at the lower transducer. This time difference can be used along with knowledge of the distance at which the transducers are placed apart to calculate the PWV, as is known in the art.
In a second embodiment an ECG arrangement is used to identify the production of an arterial pulse and the transducer is used to identify the passing of the pulse at some point further along the arterial tree. The time difference between the measurement of the ECG signal and the detection of the signal from the transducer can be calculated, and as is known in the art, used along with knowledge of the position of the doppler transducer to calculate PWV.
In a third embodiment the transducer is used for the first sensor and the second sensor is a photoplethysmography sensor. Further possibilities include using an audio-microphone, or some other sensor receptive to sound, positioned on the thorax to pick up heart sounds.
The apparatus of the invention can be used with a transducer arranged to produce electromagnetic signals of frequency in a range of between 400 MHz and 5 GHz. This range produces reflected signals from the passing pulsatile motion. However, the apparatus works in a particularly advantageous manner when the frequency is in a range of between 800MHz and 4 GHz.
Transducers for the detection of doppler shifted signals are commercially available, often for the purposes of far field detection of movement, for example Radar measurements of traffic speed. It is now found, according to the invention that such transducers can also be used for near field measurements and are surprisingly suitable for detecting the passing of pulses in the cardiovascular system.
Generally in such doppler transducers, as is known in the art, an antenna emits an electromagnetic wave which, when it is reflected from the surfaces of an object moving with a component of velocity non-transverse to the impinging electromagnetic wave, produces a shift in the frequency of the electromagnetic wave reflected back to the antenna. This shift in frequency is called the doppler shift. This doppler shifted reflected wave is then detected by an antenna in the transducer, which may or may not be the emitting transducer. The relative speed of movement of the reflecting object is encoded in the frequency shift of the detected reflected wave and this value can be extracted using known techniques.
The transducer advantageously described contains a 2.45 GHz oscillator operating in continuous mode. It is known that electromagnetic radiation is strongly absorbed in human tissue at around the frequencies of 2 to 10 GHz, but it is found, according to a highly advantageous embodiment of the invention, that the radiation produced from an antenna operating at 2.45 GHz, although absorbed and scattered to some extent by layers of tissue, produces a detectable signal.
A particularly advantageous embodiment utilizes a commercially available KMY 24 unit made by Micro Systems Engineering GmbH. It contains a 2.45 GHz oscillator and receiver in the same housing and works in continuous wave mode. The module comprises a four layered epoxy-multilayer-board with SMD-components and with triplate- filter-structures to minimize the emission of harmonics. The dimensions of the beam are, amongst other things, dependent on the dimensions of the antenna and in this case the unit contains an optimized patch antenna with minimized dimensions and a width of 3.5 cm, producing a beam with a near field radius of 2 cm. The receiver is sensitive enough to process signals that are reflected by the passing of a pulse through the emitted electromagnetic beam.
The technical steps to be performed in the processing of the recorded data to provide an output of PWV can be undertaken by a person skilled in the art using known data processing techniques. The invention also relates to a method of calculating pulse wave velocity,
PWV, along a pathway in the cardiovascular system of a subject, wherein a first time is calculated at which a first signal from a first pulse is detected by a first sensor, the first pulse originating from a first position on a pathway in the cardiovascular system of the subject, a second time is calculated at which a second signal from a second pulse is detected by a second sensor, the second pulse originating from a second position on the pathway in the cardiovascular system of the subject, the first and second positions separated by a distance along the pathway, and PWV is calculated from the values of the first position, the second position, the first time and the second time, and in which at least one sensor is a transducer arranged to emit electromagnetic signals at a certain frequency and detect doppler shifted reflected electromagnetic signals representative of a pulsatile motion occurring at the respective position in the cardiovascular system. This method has the advantage that it can be used with the apparatus to perform the invention.
The invention is further elucidated and embodiments described using the following figures.
Fig. 1 shows a high level block diagram of the features of a transducer used advantageously in the apparatus of the invention. Fig. 2 shows items of an embodiment of the apparatus of the invention applied to a human arm.
Fig. 3 shows output signals from the apparatus of Fig. 2. Fig. 4 shows a further embodiment of the apparatus of the invention applied to a subject. Fig. 5 shows a typical ECG trace which is used in the second embodiment of the invention.
Fig. 6 shows output signals from the transducer and the ECG apparatus of the second embodiment, shown in Fig. 4, when the transducer is applied to the upper arm.
Fig. 7 shows output signals from the transducer and the ECG apparatus of the second embodiment, shown in Fig. 4, when the transducer is applied to the wrist.
Figure 1 shows a high level block diagram of the features of a transducer used advantageously in the apparatus of the invention. Processing electronics 101 instruct a duplexer 102 to send electromagnetic signals of frequency fs which are emitted by an antenna 103. Reflected electromagnetic signals doppler shifted to frequency fr are received by the antenna 103, passed back to the duplexer 102 and sent to processing electronics 104 which receives the signal and calculates fo the shift in frequency between the emitted and received electromagnetic signals, as is known in the art. Although a single antenna 103 is shown here, separate antennas may be used for sending and receiving the electromagnetic signals. The shift in frequency fo is communicated to a processor 105 which performs synchronization and analysis.
Figure 2 shows the apparatus of the first embodiment of the invention. In this embodiment two transducers are applied to the arm of a subject and measure the times at which a signal is returned from the pulsatile motion along the arm caused by blood flow. The first transducer 201 is positioned over the brachial artery of the arm. The second transducer 202 is adventitiously positioned over the radial artery which provides a clear signal. The second transducer 203 can also be positioned so that the beam of electromagnetic signals is doppler shifted from pulsatile flow along the ulna artery. The skilled person will understand that the exact positioning of the two transducers is chosen to measure PWV along the arterial pathway of interest and transducers must be adjusted to provide the best signal.
It is found in practice that the transducer must be held motionless for a few seconds against the skin or clothing to allow movement artifacts to decrease and to allow whatever signal is received to be detected. It is apparent if the transducer has been misplaced to the extent that no pulsatile flow occurs in the beam of the electromagnetic signals, for in that case no signal is received.
Figure 3 shows a plot of the doppler shifted signals received from the apparatus of the first embodiment, as shown in Figure 2, and shows two traces 301 and 302, each from one of the transducers, plotted against time. The signal which occurs first temporally 301, is from the transducer of the first embodiment which is placed in the upper position on the arm. The signals are synchronously recorded. The time difference of a pulse passing each transducer is clearly visible and in this case is 50 ms. Standard algorithms, known by the skilled person, are used to automatically extract the peak-to-peak time and these are used along with the known distance between the sensors to calculate PWV, as is known in the art. It is possible to place the transducers at other parts of the body, for example along the pathways taken by arteries in the leg. If positioned correctly, it is possible to place one or both transducers over the aorta and measure the PWV of an arterial pulse along the aorta or along a pathway from the aorta to, say, the upper brachial artery. Typically, the PWV, which can be as high as 12 m/s, is higher than the flow velocity of blood, which is less than 1 m/s.
Figure 4 shows a further embodiment of the apparatus of the invention applied to a subject. In this second embodiment the second sensor is the transducer 401 and an arrangement of ECG electrodes 402, 403, 404 and processing device 405 is used to acquire the first signal. In this case the signal is the ECG signal from the heart itself. As is known in the art, measurements from electrocardiography, ECG, show that the heart pumps in a cyclical fashion and allows the identification of certain phases in the hearts electrical sequence. Figure 5 shows a typical output trace from an ECG measurement. The characteristic spikes shown in a typical trace are labeled P, Q, R, S and T. It is known that the P spike, or wave, is representative of the depolarization, or excitation, of the atria. The QRS spikes, known commonly as the QRS-complex, are representative of the excitation of the ventricles. The QRS-complex masks any signal from the repolarisation of the atria. The T spike, or T wave, is representative of the repolarisation of the ventricles.
Figure 6 shows the output signals from the transducer 601 and the ECG apparatus 602 of the second embodiment when the transducer is applied to the upper arm and therefore detects a return signal from movement of the brachial artery. Again, standard algorithms, as is known in the art, can be used to extract the time differences between the R peak and characteristic points of the doppler radar signal, as shown, and these are used, as is known in the art, to calculate PWV.
Figure 7 shows a similar output, in this case from the transducer 701 and the ECG apparatus 702 of the second embodiment when the transducer is applied to the wrist and therefore detects a return signal from movement of the radial artery. Again, standard algorithms, as is known in the art, can be used to extract the time differences between the R peak and characteristic points of the doppler radar signal, as shown, and these are used, as is known in the art, to calculate PWV.
In a third embodiment a photoplethysmography sensor is used as the second sensor. This embodiment is particularly useful during surgery when a photoplethysmography sensor is placed on the tip of a finger to monitor blood oxygenation during anesthesia. In this embodiment, the doppler transducer can be applied anywhere along the arm where access is possible under the constraints of the surgical procedure and where a suitable signal can be found. The photoplethysmography sensor, designed to detect small changes in blood volume, is used to detect the arrival of pulsatile blood flow in the tip of the finger. The PWV calculated using this embodiment can be used to provide information about the physiological status of the arteries of the upper arm during surgery.
In a further embodiment a microphone is used as the first sensor. This is particularly useful to get rid of the typically unknown pre-ejection period compared with the embodiment detecting the ECG via a first sensor, because the ECG represents the electrical excitation of the heart and on the mechanical motion of blood. In this embodiment, the doppler transducer can be applied anywhere along the arm or leg. The microphone detects heart sounds (e.g. opening and closing of the heart valves) from the thorax, which are well understood and enables the calculation of well defined time points of the start and end of a blood bolus.
Additionally it is further known that the pulse transit time and pulse wave velocity can be correlated to the blood pressure of an individual enabling beat-to-beat blood pressure readings. In particular, pulse wave velocity can be used to measure both relative arterial blood pressure changes and absolute arterial blood pressure via appropriate calibration techniques, as is known in the art, utilizing beat-to-beat blood pressure values.

Claims

CLAIMS:
1. An apparatus to measure pulse wave velocity, PWV, along a pathway in the cardiovascular system of a subject, comprising, a first sensor for placement at the surface of the subject, to detect a first signal originating from a first position on a pathway in the cardiovascular system of the subject, the first signal detected at a first time, the first sensor coupled to a processor, a second sensor for placement at the surface of the subject, to detect a second signal originating from a second position on the pathway in the cardiovascular system of the subject, the second signal detected at a second time, the second sensor coupled to the processor, the first and second positions situated a distance apart along the pathway, the processor arranged to calculate the PWV from the values of the first position, the second position, the first time and the second time, characterized in that at least one sensor is a transducer arranged to emit electromagnetic signals at a certain frequency and detect doppler shifted reflected electromagnetic signals representative of a pulsatile motion occurring at the respective position in the cardiovascular system.
2. An apparatus as claimed in claim 1, characterized in that the transducer is a constant frequency continuous wave doppler radar transducer.
3. An apparatus as claimed in claim 1 or 2, characterized in that, the first sensor is a sensor of an ECG signal receiving system and the second sensor is the transducer.
4. An apparatus as claimed in claim 1 or 2, characterized in that, one sensor is a photoplethysmography sensor.
5 An apparatus as claimed in claim 4, characterized in that, the first sensor is the transducer and the second sensor is the photoplethysmography sensor.
6. An apparatus as claimed in claim 1 or 2, characterized in that, the doppler radar system is arranged to operate at a frequency in a range of between 400 MHz and 5 GHz.
7. An apparatus as claimed in claim 1 or 2, characterized in that, the doppler radar system is arranged to operate at a frequency in a range of between 800 MHz and 4 GHz.
8. An apparatus as claimed in claim 1 or 2, characterized in that, the doppler radar system is arranged to operated at a frequency of 2.45 GHz.
9. A method of calculating pulse wave velocity, PWV, along a pathway in the cardiovascular system of a subject, comprising: calculating a first time at which a first signal from a first pulse is detected by a first sensor, the first pulse originating from a first position on a pathway in the cardiovascular system of the subject, calculating a second time at which a second signal from a second pulse is detected by a second sensor, the second pulse originating from a second position on the pathway in the cardiovascular system of the subject, the first and second positions separated by a distance along the pathway, calculating PWV from the values of the first position, the second position, the first time and the second time, characterized in that, at least one sensor is a transducer arranged to emit electromagnetic signals at a certain frequency and detect doppler shifted reflected electromagnetic signals representative of a pulsatile motion occurring at the respective position in the cardiovascular system.
PCT/IB2006/052835 2005-08-26 2006-08-17 Measurement of pulse wave velocity WO2007023426A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06795674A EP1921987A2 (en) 2005-08-26 2006-08-17 Measurement of pulse wave velocity
JP2008527558A JP2009505710A (en) 2005-08-26 2006-08-17 Pulse wave velocity measurement

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05107857.4 2005-08-26
EP05107857 2005-08-26

Publications (2)

Publication Number Publication Date
WO2007023426A2 true WO2007023426A2 (en) 2007-03-01
WO2007023426A3 WO2007023426A3 (en) 2007-05-31

Family

ID=37684456

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/052835 WO2007023426A2 (en) 2005-08-26 2006-08-17 Measurement of pulse wave velocity

Country Status (4)

Country Link
EP (1) EP1921987A2 (en)
JP (1) JP2009505710A (en)
CN (1) CN101247757A (en)
WO (1) WO2007023426A2 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009081331A1 (en) * 2007-12-19 2009-07-02 Koninklijke Philips Electronics N.V. Apparatus, method and computer program for measuring properties of an object
JP2015077395A (en) * 2013-10-17 2015-04-23 財團法人工業技術研究院Industrial Technology Research Institute Detection system and method for physiology measurement
WO2015118544A1 (en) 2014-02-05 2015-08-13 Kyma Medical Technologies Ltd. Systems, apparatuses and methods for determining blood pressure
WO2017027551A1 (en) * 2015-08-12 2017-02-16 Valencell, Inc. Methods and apparatus for detecting motion via optomechanics
US9788785B2 (en) 2011-07-25 2017-10-17 Valencell, Inc. Apparatus and methods for estimating time-state physiological parameters
US9877659B2 (en) 2012-11-30 2018-01-30 Industrial Technology Research Institute Sensing system and method for physiology measurements
US9955919B2 (en) 2009-02-25 2018-05-01 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
US10015582B2 (en) 2014-08-06 2018-07-03 Valencell, Inc. Earbud monitoring devices
US10076282B2 (en) 2009-02-25 2018-09-18 Valencell, Inc. Wearable monitoring devices having sensors and light guides
US10076253B2 (en) 2013-01-28 2018-09-18 Valencell, Inc. Physiological monitoring devices having sensing elements decoupled from body motion
WO2019000286A1 (en) * 2017-06-28 2019-01-03 悦享趋势科技(北京)有限责任公司 System for measuring pulse wave velocity (pwv)
WO2019073236A1 (en) * 2017-10-11 2019-04-18 Darren Spencer Non-invasive ambulatory monitoring of pulse transit time
RU2695925C1 (en) * 2018-02-21 2019-07-29 Публичное акционерное общество "Институт электронных управляющих машин им. И.С. Брука" Method for assessing human blood pressure (versions)
US10610158B2 (en) 2015-10-23 2020-04-07 Valencell, Inc. Physiological monitoring devices and methods that identify subject activity type
US10680324B2 (en) 2013-10-29 2020-06-09 Zoll Medical Israel Ltd. Antenna systems and devices and methods of manufacture thereof
US10827979B2 (en) 2011-01-27 2020-11-10 Valencell, Inc. Wearable monitoring device
US10959622B2 (en) 2014-02-24 2021-03-30 Koninklijke Philips N.V. Method for determining pulse wave velocity in an artery
US11020002B2 (en) 2017-08-10 2021-06-01 Zoll Medical Israel Ltd. Systems, devices and methods for physiological monitoring of patients
US11241158B2 (en) 2015-01-12 2022-02-08 Zoll Medical Israel Ltd. Systems, apparatuses and methods for radio frequency-based attachment sensing
US11259715B2 (en) 2014-09-08 2022-03-01 Zoll Medical Israel Ltd. Monitoring and diagnostics systems and methods
CN115844452A (en) * 2022-12-26 2023-03-28 北京翌影科技有限公司 Pulse wave detection method, device and storage medium
US11660008B2 (en) 2017-01-20 2023-05-30 Nokia Technologies Oy Arterial pulse measurement
US11918413B2 (en) 2015-11-03 2024-03-05 Koninklijke Philips N.V. Ultrasound probe, system and method for measuring arterial parameters using non-imaging ultrasound
US12059234B2 (en) 2020-07-06 2024-08-13 Stichting Imec Nederland Method and a system for estimating a measure of cardiovascular health of a subject

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103190891B (en) * 2013-04-26 2015-06-10 西安嵌牛电子科技有限公司 Measurement device and method for pulse wave velocity physiological parameters based on photoelectric plethysmography
MX2016007402A (en) * 2013-12-11 2016-08-19 Koninklijke Philips Nv System and method for measuring a pulse wave of a subject.
US10709383B2 (en) 2015-04-02 2020-07-14 Microsoft Technology Licnesing, Llc Wrist-worn pulse transit time sensor
CN104958064A (en) * 2015-07-15 2015-10-07 四川宇峰科技发展有限公司 Wearable arteriosclerosis detector and pulse wave velocity detecting method
WO2017198867A1 (en) * 2016-05-20 2017-11-23 Koninklijke Philips N.V. Devices and methods for determining pulse wave velocity based on changes in vessel diameter
WO2017219239A1 (en) * 2016-06-21 2017-12-28 悦享趋势科技(北京)有限责任公司 Detector for detecting state of physiological tissue, and detection method thereof
WO2018006259A1 (en) * 2016-07-05 2018-01-11 悦享趋势科技(北京)有限责任公司 Method and device for detecting physiological tissue, and detector
WO2018137250A1 (en) * 2017-01-26 2018-08-02 悦享趋势科技(北京)有限责任公司 Detection method, device and terminal for physiological data
WO2018137251A1 (en) * 2017-01-26 2018-08-02 悦享趋势科技(北京)有限责任公司 Detector and detection method for pulse wave propagation velocity
CN107280658A (en) * 2017-07-25 2017-10-24 南京恒拓精测科技有限公司 A kind of arm formula heart rate test equipment
CN110652318B (en) * 2019-07-19 2022-09-13 飞依诺科技股份有限公司 Measurement method and system for obtaining arteriosclerosis index based on ultrasonic equipment
US20240090775A1 (en) * 2019-10-18 2024-03-21 3 Aim Ip Pty Ltd. Physiological parameter sensing systems and methods
CN111150385A (en) * 2020-01-15 2020-05-15 上海科技大学 Wearable blood flow velocity sensor based on piezoelectric film
CN118078222A (en) * 2022-11-25 2024-05-28 华为技术有限公司 Apparatus, method, medium and program product for pulse wave measurement

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483860A (en) * 1964-11-02 1969-12-16 Norman Stanley Namerow Method for monitoring intrasomatic circulatory functions and organ movement
US4091385A (en) * 1976-11-24 1978-05-23 The United States Of America As Represented By The United States Department Of Energy Doppler radar flowmeter
US4926868A (en) * 1987-04-15 1990-05-22 Larsen Lawrence E Method and apparatus for cardiac hemodynamic monitor
WO2001076473A1 (en) * 2000-04-12 2001-10-18 Uutech Limited Bodily flow measuring system
US20050043608A1 (en) * 2003-08-18 2005-02-24 Haj-Yousef Yousri Mohammed Taher Method and apparatus for non-contact monitoring of cellular bioactivity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59107232D1 (en) * 1990-07-18 1996-02-22 Avl Medical Instr Ag Device and method for measuring blood pressure
US5865749A (en) * 1996-11-07 1999-02-02 Data Sciences International, Inc. Blood flow meter apparatus and method of use
JP3857788B2 (en) * 1997-09-01 2006-12-13 テルモ株式会社 Cardiovascular information measurement system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483860A (en) * 1964-11-02 1969-12-16 Norman Stanley Namerow Method for monitoring intrasomatic circulatory functions and organ movement
US4091385A (en) * 1976-11-24 1978-05-23 The United States Of America As Represented By The United States Department Of Energy Doppler radar flowmeter
US4926868A (en) * 1987-04-15 1990-05-22 Larsen Lawrence E Method and apparatus for cardiac hemodynamic monitor
WO2001076473A1 (en) * 2000-04-12 2001-10-18 Uutech Limited Bodily flow measuring system
US20050043608A1 (en) * 2003-08-18 2005-02-24 Haj-Yousef Yousri Mohammed Taher Method and apparatus for non-contact monitoring of cellular bioactivity

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHARLES D S ET AL LACOURSE J E (ED ): "PULSE WAVE VELOCITY FOR CARDIOVASCULAR CHARACTERIZATION" PROCEEDINGS OF THE IEEE 23RD. NORTHEAST BIOENGINEERING CONFERENCE. DURHAM, NEW HAMPSHIRE, MAY 21 - 22, 1997, PROCEEDINGS OF THE IEEE NORTHEAST BIOENGINEERING CONFERENCE, NEW YORK, IEEE, US, vol. CONF. 23, 21 May 1997 (1997-05-21), pages 77-78, XP000738134 ISBN: 0-7803-3849-9 cited in the application *
HARTLEY C J ET AL: "Noninvasive assessment of vascular mechanics in mice" SECOND JOINT EMBS-BMES CONFERENCE 2002. CONFERENCE PROCEEDINGS. 24TH. ANNUAL INTERNATIONAL CONFERENCE OF THE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL FALL MEETING OF THE BIOMEDICAL ENGINEERINGSOCIETY. HOUSTON, TX, OCT. 23 - 26, 2002, ANNUA, vol. VOL. 1 OF 3. CONF. 24, 23 October 2002 (2002-10-23), pages 1236-1237, XP010620045 ISBN: 0-7803-7612-9 cited in the application *
PAPP M A ET AL: "Doppler microwave. A clinical assessment of its efficacy as an arterial pulse sensing technique." INVESTIGATIVE RADIOLOGY JUL 1987, vol. 22, no. 7, July 1987 (1987-07), pages 569-573, XP009078552 ISSN: 0020-9996 *
YUNG-KANG CHEN ET AL: "A new dual channel pulse wave velocity measurement system" BIOINFORMATICS AND BIOENGINEERING, 2004. BIBE 2004. PROCEEDINGS. FOURTH IEEE SYMPOSIUM ON TAICHUNG, TAIWAN, ROC 19-21 MAY 2004, PISCATAWAY, NJ, USA,IEEE, 19 May 2004 (2004-05-19), pages 17-21, XP010711326 ISBN: 0-7695-2173-8 *

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009081331A1 (en) * 2007-12-19 2009-07-02 Koninklijke Philips Electronics N.V. Apparatus, method and computer program for measuring properties of an object
US8428699B2 (en) 2007-12-19 2013-04-23 Koninklijke Philips Electronics N.V. Apparatus, method and computer program for measuring properties of an object
US9955919B2 (en) 2009-02-25 2018-05-01 Valencell, Inc. Light-guiding devices and monitoring devices incorporating same
US10842389B2 (en) 2009-02-25 2020-11-24 Valencell, Inc. Wearable audio devices
US11471103B2 (en) 2009-02-25 2022-10-18 Valencell, Inc. Ear-worn devices for physiological monitoring
US10448840B2 (en) 2009-02-25 2019-10-22 Valencell, Inc. Apparatus for generating data output containing physiological and motion-related information
US10750954B2 (en) 2009-02-25 2020-08-25 Valencell, Inc. Wearable devices with flexible optical emitters and/or optical detectors
US11589812B2 (en) 2009-02-25 2023-02-28 Valencell, Inc. Wearable devices for physiological monitoring
US10716480B2 (en) 2009-02-25 2020-07-21 Valencell, Inc. Hearing aid earpiece covers
US11660006B2 (en) 2009-02-25 2023-05-30 Valencell, Inc. Wearable monitoring devices with passive and active filtering
US10076282B2 (en) 2009-02-25 2018-09-18 Valencell, Inc. Wearable monitoring devices having sensors and light guides
US10898083B2 (en) 2009-02-25 2021-01-26 Valencell, Inc. Wearable monitoring devices with passive and active filtering
US10827979B2 (en) 2011-01-27 2020-11-10 Valencell, Inc. Wearable monitoring device
US11324445B2 (en) 2011-01-27 2022-05-10 Valencell, Inc. Headsets with angled sensor modules
US9788785B2 (en) 2011-07-25 2017-10-17 Valencell, Inc. Apparatus and methods for estimating time-state physiological parameters
US9877659B2 (en) 2012-11-30 2018-01-30 Industrial Technology Research Institute Sensing system and method for physiology measurements
US11266319B2 (en) 2013-01-28 2022-03-08 Valencell, Inc. Physiological monitoring devices having sensing elements decoupled from body motion
US11684278B2 (en) 2013-01-28 2023-06-27 Yukka Magic Llc Physiological monitoring devices having sensing elements decoupled from body motion
US10856749B2 (en) 2013-01-28 2020-12-08 Valencell, Inc. Physiological monitoring devices having sensing elements decoupled from body motion
US10076253B2 (en) 2013-01-28 2018-09-18 Valencell, Inc. Physiological monitoring devices having sensing elements decoupled from body motion
JP2015077395A (en) * 2013-10-17 2015-04-23 財團法人工業技術研究院Industrial Technology Research Institute Detection system and method for physiology measurement
US10680324B2 (en) 2013-10-29 2020-06-09 Zoll Medical Israel Ltd. Antenna systems and devices and methods of manufacture thereof
US11108153B2 (en) 2013-10-29 2021-08-31 Zoll Medical Israel Ltd. Antenna systems and devices and methods of manufacture thereof
US11539125B2 (en) 2013-10-29 2022-12-27 Zoll Medical Israel Ltd. Antenna systems and devices, and methods of manufacture thereof
WO2015118544A1 (en) 2014-02-05 2015-08-13 Kyma Medical Technologies Ltd. Systems, apparatuses and methods for determining blood pressure
EP3102100A4 (en) * 2014-02-05 2017-11-08 Kyma Medical Technologies Ltd. Systems, apparatuses and methods for determining blood pressure
US11883136B2 (en) 2014-02-05 2024-01-30 Zoll Medical Israel Ltd. Systems, apparatuses and methods for determining blood pressure
EP4233711A3 (en) * 2014-02-05 2023-10-18 Zoll Medical Israel Ltd. Apparatuses for determining blood pressure
US11013420B2 (en) 2014-02-05 2021-05-25 Zoll Medical Israel Ltd. Systems, apparatuses and methods for determining blood pressure
US10959622B2 (en) 2014-02-24 2021-03-30 Koninklijke Philips N.V. Method for determining pulse wave velocity in an artery
US10536768B2 (en) 2014-08-06 2020-01-14 Valencell, Inc. Optical physiological sensor modules with reduced signal noise
US11252498B2 (en) 2014-08-06 2022-02-15 Valencell, Inc. Optical physiological monitoring devices
US11252499B2 (en) 2014-08-06 2022-02-15 Valencell, Inc. Optical physiological monitoring devices
US10015582B2 (en) 2014-08-06 2018-07-03 Valencell, Inc. Earbud monitoring devices
US10623849B2 (en) 2014-08-06 2020-04-14 Valencell, Inc. Optical monitoring apparatus and methods
US11330361B2 (en) 2014-08-06 2022-05-10 Valencell, Inc. Hearing aid optical monitoring apparatus
US11259715B2 (en) 2014-09-08 2022-03-01 Zoll Medical Israel Ltd. Monitoring and diagnostics systems and methods
US11241158B2 (en) 2015-01-12 2022-02-08 Zoll Medical Israel Ltd. Systems, apparatuses and methods for radio frequency-based attachment sensing
US10856812B2 (en) 2015-08-12 2020-12-08 Valencell, Inc. Methods and apparatus for detecting motion via optomechanics
WO2017027551A1 (en) * 2015-08-12 2017-02-16 Valencell, Inc. Methods and apparatus for detecting motion via optomechanics
US10610158B2 (en) 2015-10-23 2020-04-07 Valencell, Inc. Physiological monitoring devices and methods that identify subject activity type
US11918413B2 (en) 2015-11-03 2024-03-05 Koninklijke Philips N.V. Ultrasound probe, system and method for measuring arterial parameters using non-imaging ultrasound
US11660008B2 (en) 2017-01-20 2023-05-30 Nokia Technologies Oy Arterial pulse measurement
WO2019000286A1 (en) * 2017-06-28 2019-01-03 悦享趋势科技(北京)有限责任公司 System for measuring pulse wave velocity (pwv)
US11020002B2 (en) 2017-08-10 2021-06-01 Zoll Medical Israel Ltd. Systems, devices and methods for physiological monitoring of patients
US11872012B2 (en) 2017-08-10 2024-01-16 Zoll Medical Israel Ltd. Systems, devices and methods for physiological monitoring of patients
WO2019073236A1 (en) * 2017-10-11 2019-04-18 Darren Spencer Non-invasive ambulatory monitoring of pulse transit time
RU2695925C1 (en) * 2018-02-21 2019-07-29 Публичное акционерное общество "Институт электронных управляющих машин им. И.С. Брука" Method for assessing human blood pressure (versions)
US12059234B2 (en) 2020-07-06 2024-08-13 Stichting Imec Nederland Method and a system for estimating a measure of cardiovascular health of a subject
CN115844452A (en) * 2022-12-26 2023-03-28 北京翌影科技有限公司 Pulse wave detection method, device and storage medium
CN115844452B (en) * 2022-12-26 2024-05-24 北京翌影科技有限公司 Pulse wave detection method, device and storage medium

Also Published As

Publication number Publication date
EP1921987A2 (en) 2008-05-21
JP2009505710A (en) 2009-02-12
CN101247757A (en) 2008-08-20
WO2007023426A3 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
WO2007023426A2 (en) Measurement of pulse wave velocity
US20230148891A1 (en) System and method for non-invasive instantaneous and continuous measurement of heart rate, stroke volume and ejection fraction
US11877832B2 (en) Non-invasive blood pressure measurement using pulse wave velocity
EP3102100B1 (en) Apparatuses for determining blood pressure
US8834383B2 (en) Apparatus to monitor pulsating objects within the body
US20080269589A1 (en) Apparatus for the Detection of Heart Activity
US5573012A (en) Body monitoring and imaging apparatus and method
Seo et al. Noninvasive arterial blood pressure waveform monitoring using two-element ultrasound system
CN108309353B (en) Heart rate assist for phase determination in echocardiography
Vappou et al. Non-invasive measurement of local pulse pressure by pulse wave-based ultrasound manometry (PWUM)
WO2003077765A1 (en) Ultrasonographic system and ultrasonography
Buxi et al. Cuffless blood pressure estimation from the carotid pulse arrival time using continuous wave radar
US20190380677A1 (en) Method and apparatus for ultrasonic continuous measurement of blood vessel diameter
JP2005034543A (en) Monitoring device for blood flow condition
RU2695925C1 (en) Method for assessing human blood pressure (versions)
George et al. Ultrasound for Venous Local Pulse Wave Velocity: Comparison of Pulse Transit Time Methods
Patil et al. A method for localized computation of Pulse Wave Velocity in carotid structure
Xu et al. Continuous and Noninvasive Measurement of Arterial Pulse Pressure and Pressure Waveform using an Image-free Ultrasound System
Xie et al. A Flexible and Ultra-Thin Ultrasonic Sensor for Continuous Carotid Pulse Wave Monitoring
Kanai et al. Noninvasive measurement of small local vibrations in the heart or arterial wall
TWI495452B (en) Apparatus and method for cardiovascular pulse measurement by using electrical pulses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006795674

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008527558

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 200680030987.5

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 943/CHENP/2008

Country of ref document: IN

NENP Non-entry into the national phase in:

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2006795674

Country of ref document: EP